To administratively DE-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30, 2026, closing of the period of…

The National Cancer Institute awarded a Blanket Purchase Agreement (BPA) call valued at $153,662.40 to Astrix Technology LLC for scientific support services. The contract, issued on October 19, 2020, with an ultimate completion date of October 17, 2021, was executed under the General Services Administration's Multiple Award Schedule with no set-aside designations, allowing unrestricted competition. The award documentation indicates this action was undertaken to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability for these fiscal year funds. Performance is to be conducted at the NCI facility in Bethesda, Maryland.

Astrix Technology LLC, a Red Bank, New Jersey-based staffing and scientific support services provider, specializes in delivering flexible personnel solutions to federal biomedical research agencies, particularly the National Institutes of Health and its constituent institutes. The company maintains a significant single-award BPA with the NIH Office of Logistics and Acquisition Operations valued at $20 million through May 31, 2025, under which this task order falls. Astrix Technology has an extensive track record across the NIH enterprise, providing scientific researchers, senior scientists, clinical research nurses, laboratory technicians, biostatisticians, program managers, and administrative personnel to support complex research initiatives and operational requirements across multiple NIH institutes and centers.

To administratively DE-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30, 2026, closing of the period of availability of these fiscal year funds